The Hippo signaling pathway is required for salivary gland development and its dysregulation is associated with Sjogren's-like disease
View/ Open
Author
Enger, Tone Berge
Samad-Zadeh, Arman
Bouchie, Meghan
Skarstein, Kathrine
Galtung, Hilde Kanli
Walker, Janice
Menko, A. Sue
Varelas, Xaralabos
Jensen, Janicke Liaaen
Kukuruzinska, Maria
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1038/labinvest.2013.114Metadata
Show full item recordCitation
Enger, T. B., A. Samad-Zadeh, M. Bouchie, K. Skarstein, H. K. Galtung, T. Mera, J. Walker, et al. 2013. “The Hippo signaling pathway is required for salivary gland development and its dysregulation is associated with Sjogren's-like disease.” Laboratory investigation; a journal of technical methods and pathology 93 (11): 10.1038/labinvest.2013.114. doi:10.1038/labinvest.2013.114. http://dx.doi.org/10.1038/labinvest.2013.114.Abstract
Sjogren's syndrome (SS) is a complex autoimmune disease that primarily affects salivary and lacrimal glands and is associated with high morbidity. Although the prevailing dogma is that immune system pathology drives SS, increasing evidence points to structural defects, including defective E-cadherin adhesion, to be involved in its etiology. We have shown that E-cadherin plays pivotal roles in the development of the mouse salivary submandibular gland (SMG) by organizing apical-basal polarity in acinar and ductal progenitors and by signaling survival for differentiating duct cells. Recently, E-cadherin junctions have been shown to interact with effectors of the Hippo signaling pathway, a core pathway regulating organ size, cell proliferation and differentiation. We now show that Hippo signaling is required for SMG branching morphogenesis and is involved in the pathophysiology of SS. During SMG development, a Hippo pathway effector, TAZ, becomes increasingly phosphorylated and associated with E-cadherin and α-catenin, consistent with the activation of Hippo signaling. Inhibition of Lats2, an upstream kinase that promotes TAZ phosphorylation, results in dysmorphogenesis of the SMG and impaired duct formation. SMGs from NOD mice, a mouse model for SS, phenocopy the Lats2-inhibited SMGs and exhibit a reduction in E-cadherin junctional components, including TAZ. Importantly, labial specimens from human SS patients display mislocalization of TAZ from junctional regions to the nucleus, coincident with accumulation of extracellular matrix components, fibronectin and CTGF, known downstream targets of TAZ. Our studies show that Hippo signaling plays a crucial role in SMG branching morphogenesis and provide evidence that defects in this pathway are associated with SS in humans.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864807/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:12407001
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)